Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bardet-Biedl Syndrome | 9 | 2026 | 9 | 4.080 |
Why?
|
| Hyperphagia | 5 | 2025 | 15 | 2.120 |
Why?
|
| Receptor, Melanocortin, Type 4 | 2 | 2025 | 9 | 1.150 |
Why?
|
| Weight Gain | 7 | 2025 | 139 | 0.850 |
Why?
|
| Psychometrics | 1 | 2025 | 358 | 0.780 |
Why?
|
| Obesity | 12 | 2026 | 1151 | 0.710 |
Why?
|
| Child | 13 | 2026 | 3443 | 0.660 |
Why?
|
| Exercise | 8 | 2025 | 692 | 0.650 |
Why?
|
| Life Style | 6 | 2025 | 334 | 0.600 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 539 | 0.510 |
Why?
|
| Child, Preschool | 9 | 2025 | 1546 | 0.480 |
Why?
|
| Body Composition | 6 | 2024 | 159 | 0.470 |
Why?
|
| Pregnancy Complications | 3 | 2025 | 140 | 0.460 |
Why?
|
| alpha-MSH | 2 | 2026 | 6 | 0.460 |
Why?
|
| Adult | 21 | 2026 | 13872 | 0.430 |
Why?
|
| Registries | 3 | 2026 | 437 | 0.380 |
Why?
|
| Humans | 31 | 2026 | 43102 | 0.370 |
Why?
|
| Diet | 5 | 2025 | 826 | 0.370 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2022 | 40 | 0.370 |
Why?
|
| Adolescent | 8 | 2026 | 6081 | 0.370 |
Why?
|
| Female | 25 | 2026 | 24698 | 0.360 |
Why?
|
| Body Mass Index | 9 | 2026 | 925 | 0.330 |
Why?
|
| Overweight | 3 | 2025 | 249 | 0.330 |
Why?
|
| Infant | 7 | 2025 | 1175 | 0.320 |
Why?
|
| Sleep | 3 | 2021 | 185 | 0.310 |
Why?
|
| Male | 18 | 2026 | 23409 | 0.310 |
Why?
|
| Cross-Sectional Studies | 9 | 2025 | 3156 | 0.300 |
Why?
|
| Cardiovascular Diseases | 3 | 2022 | 749 | 0.260 |
Why?
|
| Physical Fitness | 2 | 2017 | 90 | 0.250 |
Why?
|
| Nevus, Pigmented | 1 | 2025 | 6 | 0.240 |
Why?
|
| Health Promotion | 2 | 2025 | 704 | 0.230 |
Why?
|
| Cost of Illness | 1 | 2025 | 98 | 0.220 |
Why?
|
| Young Adult | 5 | 2026 | 5080 | 0.210 |
Why?
|
| Chaperonins | 2 | 2022 | 5 | 0.210 |
Why?
|
| Longitudinal Studies | 4 | 2021 | 1063 | 0.210 |
Why?
|
| Infant, Newborn | 3 | 2025 | 972 | 0.210 |
Why?
|
| Pregnancy | 7 | 2025 | 1772 | 0.200 |
Why?
|
| Quality of Life | 2 | 2025 | 616 | 0.200 |
Why?
|
| Caregivers | 1 | 2025 | 197 | 0.190 |
Why?
|
| Cohort Studies | 3 | 2026 | 1759 | 0.190 |
Why?
|
| Body Weight | 2 | 2024 | 429 | 0.190 |
Why?
|
| Renal Insufficiency | 1 | 2022 | 19 | 0.180 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2021 | 4 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2022 | 760 | 0.170 |
Why?
|
| Insulin Resistance | 1 | 2022 | 201 | 0.170 |
Why?
|
| Counseling | 2 | 2025 | 138 | 0.160 |
Why?
|
| Body Height | 1 | 2020 | 53 | 0.160 |
Why?
|
| Genetic Markers | 1 | 2020 | 150 | 0.160 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2020 | 95 | 0.150 |
Why?
|
| Vitamin D | 1 | 2021 | 196 | 0.150 |
Why?
|
| Age Factors | 2 | 2020 | 1154 | 0.150 |
Why?
|
| Sex Factors | 2 | 2020 | 1028 | 0.150 |
Why?
|
| Feeding Behavior | 3 | 2020 | 469 | 0.140 |
Why?
|
| Energy Intake | 1 | 2019 | 164 | 0.140 |
Why?
|
| Genotype | 1 | 2020 | 800 | 0.130 |
Why?
|
| Phenotype | 1 | 2020 | 780 | 0.130 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 40 | 0.130 |
Why?
|
| Middle Aged | 5 | 2026 | 12222 | 0.130 |
Why?
|
| Sweden | 4 | 2017 | 18 | 0.130 |
Why?
|
| Parents | 2 | 2017 | 370 | 0.130 |
Why?
|
| Leisure Activities | 1 | 2016 | 41 | 0.120 |
Why?
|
| Bone Development | 1 | 2016 | 28 | 0.120 |
Why?
|
| Muscle Development | 1 | 2016 | 51 | 0.120 |
Why?
|
| Self Efficacy | 1 | 2017 | 215 | 0.120 |
Why?
|
| Habits | 1 | 2015 | 8 | 0.120 |
Why?
|
| Prevalence | 1 | 2020 | 1612 | 0.120 |
Why?
|
| Exercise Tolerance | 1 | 2015 | 22 | 0.120 |
Why?
|
| Primary Prevention | 1 | 2015 | 63 | 0.120 |
Why?
|
| Child Development | 1 | 2016 | 99 | 0.120 |
Why?
|
| Acculturation | 1 | 2017 | 205 | 0.120 |
Why?
|
| Diet Records | 1 | 2015 | 58 | 0.110 |
Why?
|
| Adiposity | 1 | 2016 | 157 | 0.110 |
Why?
|
| Mexican Americans | 1 | 2017 | 226 | 0.110 |
Why?
|
| Heart Defects, Congenital | 1 | 2015 | 72 | 0.110 |
Why?
|
| Exercise Therapy | 1 | 2015 | 87 | 0.110 |
Why?
|
| Risk Factors | 2 | 2020 | 3994 | 0.110 |
Why?
|
| Maternal-Fetal Relations | 1 | 2014 | 1 | 0.110 |
Why?
|
| Weight Loss | 2 | 2026 | 137 | 0.110 |
Why?
|
| Adipokines | 1 | 2014 | 28 | 0.110 |
Why?
|
| Birth Weight | 1 | 2014 | 95 | 0.100 |
Why?
|
| Telemedicine | 1 | 2017 | 234 | 0.100 |
Why?
|
| Motor Activity | 1 | 2015 | 437 | 0.100 |
Why?
|
| Health Behavior | 1 | 2016 | 575 | 0.090 |
Why?
|
| Health Status Disparities | 1 | 2017 | 719 | 0.080 |
Why?
|
| Treatment Outcome | 2 | 2026 | 1604 | 0.080 |
Why?
|
| Puerto Rico | 2 | 2025 | 1413 | 0.070 |
Why?
|
| Poverty | 2 | 2025 | 400 | 0.070 |
Why?
|
| Muscle Strength | 2 | 2017 | 37 | 0.060 |
Why?
|
| Alaska | 2 | 2017 | 62 | 0.060 |
Why?
|
| Blood Glucose | 2 | 2021 | 389 | 0.060 |
Why?
|
| Postpartum Period | 2 | 2017 | 92 | 0.060 |
Why?
|
| Hunger | 1 | 2024 | 12 | 0.050 |
Why?
|
| Waist Circumference | 1 | 2024 | 90 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 1067 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2025 | 178 | 0.050 |
Why?
|
| Time Factors | 2 | 2019 | 1857 | 0.050 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2022 | 34 | 0.050 |
Why?
|
| Cholesterol, HDL | 1 | 2022 | 99 | 0.050 |
Why?
|
| Mothers | 1 | 2025 | 215 | 0.050 |
Why?
|
| Penetrance | 1 | 2022 | 7 | 0.050 |
Why?
|
| Triglycerides | 1 | 2022 | 147 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 112 | 0.040 |
Why?
|
| Fishes | 1 | 2022 | 73 | 0.040 |
Why?
|
| Vitamin D Deficiency | 1 | 2021 | 107 | 0.040 |
Why?
|
| Glucose | 1 | 2022 | 244 | 0.040 |
Why?
|
| Walking | 1 | 2021 | 88 | 0.040 |
Why?
|
| Seasons | 1 | 2019 | 139 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 375 | 0.040 |
Why?
|
| Aged | 3 | 2016 | 8214 | 0.040 |
Why?
|
| Cytokines | 1 | 2022 | 678 | 0.030 |
Why?
|
| Least-Squares Analysis | 1 | 2017 | 45 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2021 | 363 | 0.030 |
Why?
|
| Motor Skills | 1 | 2017 | 46 | 0.030 |
Why?
|
| Mutation | 1 | 2022 | 1177 | 0.030 |
Why?
|
| Plethysmography, Whole Body | 1 | 2016 | 1 | 0.030 |
Why?
|
| Income | 1 | 2017 | 160 | 0.030 |
Why?
|
| Inflammation | 1 | 2022 | 758 | 0.030 |
Why?
|
| Mexico | 1 | 2017 | 298 | 0.030 |
Why?
|
| Child Behavior | 1 | 2016 | 81 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2017 | 182 | 0.030 |
Why?
|
| United States | 2 | 2017 | 5205 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2016 | 263 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2019 | 666 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2016 | 490 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2015 | 224 | 0.030 |
Why?
|
| Age Distribution | 1 | 2015 | 249 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 317 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 638 | 0.030 |
Why?
|
| Adiponectin | 1 | 2014 | 59 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2014 | 165 | 0.020 |
Why?
|
| Leptin | 1 | 2014 | 118 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 1078 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2015 | 863 | 0.020 |
Why?
|
| Insulin | 1 | 2014 | 258 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 1600 | 0.020 |
Why?
|
| Animals | 1 | 2022 | 16992 | 0.010 |
Why?
|